在基因疗法和基因编辑时代,对输血依赖β-thalassemia的治疗终点进行定义
Selim Corbacioglu1, Haydar Frangoul2, Franco Locatelli3
1University of Regensburg, Regensburg, Germany.
American journal of hematology
|December 15, 2023
概括
输血依赖β-thalassemia (TDT) 治疗正在发展,基因疗法提供潜在的治疗方法. 本综述讨论了TDT病理生理学,新兴的基因疗法,以及评估治疗效果的关键终点.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 医学研究 医学研究
背景情况:
- β-thalassemia 是一种单一性贫血,具有输血依赖性 (TDT) 形式,其特征是无效的红质形成和并发症,如铁过载.
- 目前的TDT治疗治疗治疗症状,而不是根本原因,除了全源造血细胞移植外.
- 新型基因添加和基因编辑疗法正在临床试验中,旨在为TDT提供一次性功能治疗.
研究的目的:
- 为提供TDT病理生理学的概述.
- 在临床试验中审查TDT的新兴基因添加和基因编辑治疗方法.
- 确定治疗效果量化的终点,区分治愈和改善的结果.
主要方法:
- 关于TDT病理生理学的文献综述.
- 对TDT目前的基因添加和基因编辑临床试验的分析.
- 开发一个评估治疗终点的框架.
主要成果:
- 详细的TDT病理生理学,包括无效的红色素和二次并发症.
- 针对TDT进行研究的各种基因疗法策略的摘要.
- 拟议的一组终点来评估新型TDT治疗的治疗潜力.
结论:
- 基因疗法代表了TDT的有希望的治疗方法,超越了症状管理.
- 标准化终点对于严格评估这些新型遗传治疗方法的疗效和治愈潜力至关重要.
- 需要进一步的研究和临床验证,以确定基因基因TDT疗法的最终治愈结果.
更多相关视频
12:04Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
3.6K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.4K
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
CRISPR
51.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.6K
